Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists von Mileham, Kathryn F., Schenkel, Caroline, Bruinooge, Suanna S., Freeman‐Daily, Janet, Basu Roy, Upal, Moore, Amy, Smith, Robert A., Garrett‐Mayer, Elizabeth, Rosenthal, Lauren, Garon, Edward B., Johnson, Bruce E., Osarogiagbon, Raymond U., Jalal, Shadia, Virani, Shamsuddin, Weber Redman, Mary, Silvestri, Gerard A.

Volltext

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy von Smith, Margaret R., Wang, Yuezhu, D’Agostino, Ralph, Liu, Yin, Ruiz, Jimmy, Lycan, Thomas, Oliver, George, Miller, Lance D., Topaloglu, Umit, Pinkney, Jireh, Abdulhaleem, Mohammed N., Chan, Michael D., Farris, Michael, Su, Jing, Mileham, Kathryn F., Xing, Fei

Volltext

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report von Thummalapalli, Rohit, Choudhury, Noura J., Ehrich, Fiona, Beardslee, Tyler, Brazel, Danielle, Zhang, Shannon S., Merchant, Shelby, Chen, Monica F., Heller, Glenn, Ramalingam, Suresh S., Ou, Sai-Hong Ignatius, Mileham, Kathryn F., Riely, Gregory J.

Volltext

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement von Tsimberidou, Apostolia M, Levit, Laura A, Schilsky, Richard L, Averbuch, Steven D, Chen, Daniel, Kirkwood, John M, McShane, Lisa M, Sharon, Elad, Mileham, Kathryn F, Postow, Michael A

Volltext

Initial Results from Mobile Low‐Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations von Raghavan, Derek, Wheeler, Mellisa, Doege, Darcy, Doty, John D., Levy, Henri, Dungan, Kia A., Davis, Lauren M., Robinson, James M., Kim, Edward S., Mileham, Kathryn F., Oliver, James, Carrizosa, Daniel

Volltext

Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer von Smith, Sonali M., Wachter, Kerri, Burris, Howard A., Schilsky, Richard L., George, Daniel J., Peterson, Douglas E., Johnson, Melissa L., Markham, Merry Jennifer, Mileham, Kathryn F., Beg, Muhammad S., Bendell, Johanna C., Dreicer, Robert, Keedy, Vicki L., Kimple, Randall J., Knoll, Miriam A., LoConte, Noelle, MacKay, Helen, Meisel, Jane Lowe, Moynihan, Timothy J., Mulrooney, Daniel A., Mulvey, Therese Marie, Odenike, Olatoyosi, Pennell, Nathan A., Reeder-Hayes, Katherine, Smith, Cardinale, Sullivan, Ryan J., Uzzo, Robert

Volltext

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study von Duvivier, Herbert L, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Ahn, Eugene R, Al Baghdadi, Tareq, Alva, Ajjai S, Dublis, Stephanie A, Cannon, Timothy L, Calfa, Carmen J, Li, Rui, Behl, Deepti, Chiu, Vi K, Gold, Philip J, Marr, Alissa S, Mileham, Kathryn F, Powell, Steven Francis, Rodon, Jordi, Thota, Ramya, Grantham, Gina N, Gregory, Abigail, Hinshaw, Dominique C, Halabi, Susan, Schilsky, Richard L

Volltext

Rate of COVID‐19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome‐coronavirus 2: Analysis of the American Society of Clinical Oncolo... von Kurbegov, Dax, Bruinooge, Suanna S., Lei, Xiudong Jennifer, Kirkwood, M. Kelsey, Dickson, Natalie, Hattiangadi, Trupti, Mileham, Kathryn F., Patrick, Alicia, Williams, Jen Hanley, Kaltenbaugh, Melinda, Gralow, Julie R., Garrett‐Mayer, Elizabeth

Volltext

Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study von Eisner, Joel R, Mayhew, Gregory M, Davison, James M, Beebe, Kirk D, Shibata, Yoichiro, Guo, Yuelong, Farhangfar, Carol, Farhangfar, Farhang, Uronis, Joshua M, Conroy, Jeffrey M, Milburn, Michael V, Hayes, David Neil, Mileham, Kathryn F

Volltext

Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? von Mileham, Kathryn F., Farhangfar, Carol J.

Volltext

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group von Harvey, R. Donald, Mileham, Kathryn F., Bhatnagar, Vishal, Brewer, Jamie R., Rahman, Atiqur, Moravek, Cassadie, Kennedy, Andrew S., Ness, Elizabeth A., Dees, E. Claire, Ivy, S. Percy, Ebbinghaus, Scot W., Schenkel, Caroline, Uldrick, Thomas S.

Volltext

Supportive Oncology in Lung Cancer: Program Development for Patients and Care Partners von Beeler, Dori, Mileham, Kathryn F., York, Beth, Szafranski, Michele, Walsh, Declan

Volltext

Efficacy and Safety Results of the Afatinib Expanded Access Program von Kim, Edward S., Halmos, Balazs, Kohut, Ingrid F., Patel, Taral, Rostorfer, Regan D., Spira, Alexander I., Cseh, Agnieszka, McKay, John, Wallenstein, Gudrun, Mileham, Kathryn F.

Volltext

Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual von Mileham, Kathryn F, Kim, Edward S

Volltext

Treatment of advanced squamous cell carcinoma of the lung: a review von Derman, Benjamin A., Mileham, Kathryn F., Bonomi, Philip D., Batus, Marta, Fidler, Mary J.

Volltext

Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies von Smith, Margaret R., Wang, Yuezhu, Dixon, Caroline B., D'Agostino, Ralph, Liu, Yin, Ruiz, Jimmy, Oliver, George, Miller, Lance D., Topaloglu, Umit, Chan, Michael D., Farris, Michael, Su, Jing, Mileham, Kathryn F., Li, Wencheng, Grayson, Jason M., Lycan, Thomas, Xing, Fei

Volltext

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement von Tsimberidou, Apostolia M, Levit, Laura A, Schilsky, Richard L, Averbuch, Steven D, Chen, Daniel, Kirkwood, John M, McShane, Lisa M, Sharon, Elad, Mileham, Kathryn F, Postow, Michael A

Volltext

Targeted Therapy for Mutation-Driven Metastatic Non-Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors von Mileham, Kathryn F, Ahmad, Mufti N, Kim, Edward S

Volltext

Phosphodiesterase Inhibition to Sensitize Non-Small-Cell Lung Cancer to Pemetrexed: A Double-Edged Strategy von Ivanina Foureau, Anna V, Foureau, David M, McHale, Cody C, Guo, Fei, Farhangfar, Carol J, Mileham, Kathryn F

Volltext

The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review von Heinzerling, John H., Mileham, Kathryn F., Simone, Charles B.

Volltext